RecallRadar

FDA Drug recall D-1179-2022

Enalapril Maleate Tablets, USP

On 2022-07-13 the FDA classified a Class II recall of Enalapril Maleate Tablets, USP by Golden State Medical Supply, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1179-2022
ClassificationClass II
Statusongoing
Initiated2022-03-16
Published2022-07-13
Last updated2026-09-13 11:52 UTC
CompanyGolden State Medical Supply
DistributionUS

Product

Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.

Reason

CGMP Deviations

Identifiers

ndc60429-183-30
ndc60429-183-10
ndc60429-183-90
ndc60429-184-30
ndc60429-184-10
ndc60429-184-90
ndc60429-185-30
ndc60429-185-10
ndc60429-185-90
ndc60429-186-30
ndc60429-186-10
ndc60429-186-90
code_info
Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS02962…Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527, GS034231, Exp.: 10/2022; Lots: GS034810, Exp.: 01/2023; Lots: GS035240, GS035598, Exp.: 05/2023; Lots: GS036194, Exp.: 06/2023; Lots: GS036760, GS036981,GS037526, GS038177, GS038728, Exp.: 08/2023; Lots: GS038729, GS041108, Exp.: 09/2023; Lots: GS039412, GS039840, GS041109, Exp.: 12/2023; Lot: GS041655, Exp.: 01/2024; Lot: GS041656, Exp.: 05/2024. (NDC: 60429-185-90).

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1179-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.